Trial Profile
Combination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary) ; Deferoxamine (Primary)
- Indications Iron overload
- Focus Therapeutic Use
- 15 Dec 2015 New trial record